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Summary individuals. Undlien et al. (1995), using an independent
set of data, found no such difference in the parental
The marker-association-segregation-x2 (MASC) method
origin of susceptibility. Here we reconsider the data used
with consideration of age, for nonaffected persons, and
by Margaritte-Jeannin et al. (1995) and introduce risks
of age at onset, for affected persons, was applied to a
of expressing the disease as functions not only of geno-
sample of 308 HLA-typed families. Hazard rates model-
types but also of age.
ing the instantaneous risk of catching the disease were
estimated under the exponential distribution and with Material and Methods
satisfactory goodness of ﬁt. This class of models shows
Margaritte-Jeanin et al. considered a sample compris-that the hypothesis of the absence of parental imprinting
ing (a) 390 French families followed by I. Deschampscannot be rejected for insulin-dependent diabetes mel-
and HLA typed in J. Hors’s laboratory and (b) 94 Cau-litus.
casian families from the Genetic Analysis Workshop 5
data (Clerget-Darpoux and Babron 1989; Spielman et
Introduction al. 1989). From these 416 families, we retained only
those for which age, for nonaffected individuals, or ageCudworth and Woodrow (1975) showed that a genetic
at onset, for affected individuals, was known for allfactor located in the HLA region is involved in the etiol-
members of the families. The ﬁnal reduced sample com-ogy of type 1 insulin-dependent diabetes mellitus
prised 308 HLA-DR typed families with information(IDDM). However, Hodge et al. (1980), Risch (1984),
on age. These families were classiﬁed into two familialClerget-Darpoux et al. (1986), and Louis and Thomson
conﬁgurations: 207 families in which no parent and no(1986) agreed that a single allele of susceptibility was
sib was affected (conﬁguration C1) and 101 families innot enough to ﬁt the observations.
which no parent and at least one sib of the index wasNotably, Deschamps et al. (1990) found that 62% of
affected (conﬁguration C2). All individuals were typedtheir sample of 130 unrelated DR3DR4 patients without
at HLA loci A, B, C, and DR, enabling determinationaffected parents inherited the DR3 allele from their
of identity by descent (IBD) (0, 1, or 2).mothers. Therefore, Clerget-Darpoux et al. (1991) ﬁt a
The marker-association-segregation-x2 (MASC)model with maternal effect associated with the DR3
method was introduced by Clerget-Darpoux et al.antigen and a ‘‘complementation’’ effect, deﬁned as the
(1988, p. 248) ‘‘to take into account the simultaneouspresence of two alleles of susceptibility that are located
information of segregation and association of a markerat two loci of the HLA region.
and a disease,’’ as well as the risk that some relatives ofMargaritte-Jeannin et al. (1995) concluded in favor
the patients would be affected. Patients are classiﬁedof parental imprinting on a speciﬁc allele combination
according to their familial conﬁguration (one or no sib-in the HLA region. They showed that, if maternal effect
lings affected), marker genotype, and degree of IBD with(Clerget-Darpoux et al. 1991) could not be retained,
a randomly chosen sib. Then, a model of segregation isthen parental imprinting, which reﬂects a different role
ﬁt either by likelihood maximization, in which age isof the same allele when transmitted by the father or by
considered, or, alternatively, by x2 minimization, inthe mother, could be a good candidate for explaining the
which age is not considered. It is noteworthy that thisobserved distributions of DR3 and DR4 among affected
model is based on the probability fij of being affected
when having the genotype SiSj. This probability, called
‘‘penetrance,’’ is usually assumed to be constant withReceived September 13, 1996; accepted for publication April 11,
1997. age, which may not be a reasonable assumption for
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The MASC method basically compares observed and he or she dies from another cause before onset of the
disease. At the time of survey, we record the individual’stheoretical probabilities that two sibs, one of whom is
the affected proband, are IBD for two haplotypes (IBD age as a minimal (censored) endpoint to his or her period
of risk.Å 2), one haplotype only (IBD Å 1), or no haplotype at
all (IBD Å 0). These probabilities are conditioned, ﬁrst, Following Cox and Oakes (1984), Elston (1973),
Bonney (1986), and Abel and Bonney (1990), we takeby the familial conﬁguration with respect to affected
statuses and, second, on the information provided by each penetrance fij relative to the genotype SiSj, as the
instantaneous risk hij(a) of being affected at age a, asthe marker locus. In other words, we calculate XCikl
Å P(IBD Å 2/Ci / ind Å MkMl aff); YCikl Å P(IBD Å 1/ hij(a) Å limDr0/[P(a £ T õ a / D/a £ T)]/D, where T
is the random variable ‘‘age at onset.’’ The probabilityCi / ind Å MkMl aff); ZCikl Å P(IBD Å 0/Ci / ind
Å MkMl aff), where Ci denotes the familial conﬁgura- of surviving in the healthy state until age a is Fij(a)
Å P(T ú a); hence, [dFij(a)/da] Å 0hij(a)Fij(a). Aftertion, Mk is the kth allele of the marker locus M, and
‘‘aff’’ and ‘‘ind’’ are abbreviations for ‘‘affected’’ and integration, Fij(a) Å exp[0a0 hij(b)db]. The notion of
instantaneous risk supersedes the notion of penetrance.‘‘index,’’ respectively.
The candidate gene, whose recombination fraction Each individual is now viewed as being susceptible to
the disease, whatever his or her affected status. In thewith regard to the Marker locus is assumed to be negligi-
ble, is denoted S and its ith allelic form is denoted Si. case of an unaffected person, at the moment of the sur-
vey, we consider this observation as being censored. AnThe penetrance of a pair SiSj, denoted as fij, is the proba-
bility that a zygote contracts the disease when he or she affected person will contribute to the likelihood through
a term Fij(a)hij(a), where a is the age at onset in thathas SiSj in his or her genotype: fij Å P(aff/SiSj). The
probabilities UCikl , UÅX,Y,Z, respectively, are then writ- person, whereas an unaffected person will contribute to
the likelihood through a term Fij(a), where a is the ageten as explicit functions of these penetrances fij, of the
frequencies of the markers, of the probabilities for the of the person at the moment of the investigation. The
main difﬁculty arising in the introduction of survivalparents to have given markers, of the probability of
having n sibs, and of the familial conﬁguration. The data analysis into the MASC method is in accounting
for the contributions brought by the various memberscomparison with observed values of the UCikl , UÅX,Y,Z,
respectively, is obtained either through minimizing a x2 of a given family. A simple parameterization is the expo-
nential family, because penetrances fij are replaced one-statistic with respect to the fij’s or maximizing an appro-
priate likelihood, which is the product of the (UCikl )n
Ci
kl , U to-one by constant instantaneous risks hij(a) Å hij for all
values of a. Subsequently, in the exponential speciﬁca-Å X,Y,Z, where nCikl is the number of individuals of
marker kl and familial conﬁguration Ci. tion, the survival function is Fij(a) Å exp(0hija). The
ages or ages at onset of parents af and am, for father andFor example,
mother, respectively, are introduced, as well as the ages
or the ages of onset in the n sibs, ask, k Å 1, . . . , n.
The probabilities UCikl , U Å X,Y,Z, respectively, are re-
∑
i,j
aijklfij∑
s,t
bijst∑
n
(10fijst)nvklnC1(10 fij)/[4(10fijst)]
∑
i,j
aijkl fij∑
s,t
bijst∑
n
(10fijst)nvklnC1 , written to account for the parameterization of pene-
trances by use of instantaneous risks; for example, the
(1) bijst term in equation (1) is rewritten as bijst(af,am)
Å {qsqt[Ftj(af)Fis(am) / Ftj(am)Fis(af)]/2} in the case of one
affected parent; the (1 0 fijst)n are replaced by PnkÅ1{1where fijst Å (fij/fit/fjs/fst)/4, bijst Å qsqt(1 0 fsi)(1
0 ftj) (qs is the probability that one parent of the indi- 0 [hijFij(ask) / hitFit(ask) / hjsFjs(ask) / hstFst(ask)]}/4,
where k denotes the kth sib. Similarly, for each familyvidual typed as SiSj has the haplotype Ss), aijkl
Å P(SiSjMkMl), vklnC1 is the probability of n sibs when (Ci, ind aff, a,af,am,as), the equivalent forms of the
UCikl , UCikl (a,af,am,as1, . . . , asn), U Å X,Y,Z are computed.the index is MkMl, the conﬁguration is C1, and there
exists at least one sib. For further detailed formulas, see Finally, the expected number of individuals in each class
(familial conﬁguration 1 marker genotype 1 degree ofthe work of Clerget-Darpoux et al. (1988).
We extended this method to the case of age-dependent IBD with a randomly chosen sib) can be derived, and a
x2 test of goodness of ﬁt is conducted.onset of disease. In this case, as commonly practiced in
survival data analysis, each individual is considered as We simulated several (three) sets of 100 samples of
308 families of C1 and C2, in which the risk of con-being at risk of contracting the disease. If the individual
is already affected, then his or her age at onset is re- tracting the disease, fij(a), has an exponential distribu-
tion of intensity hij, i Å 1,2, j Å 1,2. (The study to docorded as the deﬁning endpoint to his or her period of
risk. If the individual is not affected at the moment of would be to make the three parameters h11 , h12 , and h22
describe the whole space of possible values. For eachthe survey, we consider that this person is still at risk
and will certainly become affected in the future, unless point of this three-dimensional space, we would have to
/ 9a2d$$jy08 07-08-97 18:01:10 ajhga UC-AJHG
225Bonneuil et al.: Age at Onset in IDDM
Table 2simulate 100 samples to run the models. Because of the
computation time required, however, we were content
Model 2 of Hazard-Rates Matrix, with Imprinting
with trying three different sets of parameters, choosing
different situations—[1] h11 Å .01, h12 Å h21 Å .01, and MATERNAL ALLELE
h22 Å .001; [2] h11 Å .05, h12 Å h21 Å .02, and h22 Å .01;
PATERNAL ALLELE a0b0 a0b ab0 aband [3] h11 Å .006, h12 Å h21 Å .005, and h22 Å .00—
and the coupling frequencies c11 Å .25 between S1 and
a0b0 H L H MM1 and c22 Å .75 between S2 and M1 , as well as the a0b H 0 H 0
frequency of the genes, .2 for S1 [and .8 for S2].) Al- ab0 L L 0 0
ab M 0 0 0though the models with age-dependent penetrances and
with penetrances constant with age are not statistically
comparable, because they are not nested models, we
also ran, on these same 100 samples, the model with
with complementation effect is equivalent to a one-locuspenetrances constant with age. We saw that the model
model with four alleles, where S1 Å a0b0 , S2 Å a0b, S3with penetrances constant with age can produce good- Å ab0 , and S4 Å ab. The model involves the instanta-ness of ﬁt comparable to that of the model with age-
neous risks hij, i, j Å 1, . . . ,4, and the 12 couplingdependent penetrances. Goodness of ﬁt, of course, is not
probabilities cij between the disease alleles Si, i Å 1, . . . ,a sufﬁcient criterion by which to assess the appropriate-
4 and the marker alleles DR3, DR4, and DRX. Noteness of a model, and, for diseases with a delayed age
that, for all j, Sicij Å 1 and that the frequency of the ithat onset, the model with age-dependent penetrances is
disease allele is Sj√{3,4,X}cijP (DRj).preferred from a biological standpoint. We also simu-
Since affected individuals have either a0 or b0 , thelated three series of 100 samples with penetrances con-
instantaneous risks of genotypes lacking in a0 and b0stant with age, on which we ran models based on age-
are constrained to 0. As already suggested by Clerget-dependent penetrances, as well as models with pene-
Darpoux et al. (1991), taking advantage of the study oftrances constant with age. Similarly, the criterion of
Khalil et al. (1990), we assume that susceptibility is duegoodness of ﬁt does not permit us to distinguish a ‘‘bet-
to a speciﬁc heterodimer on the cell surface. Subse-ter’’ model, since the models with age-dependent pene-
quently, the coupling probabilities of DR3 with b andtrances and the models with penetrances constant with
those of DR4 with a are set to 0, as are those of DRXage do not give signiﬁcantly different goodness of ﬁt.
with a0b0 .For the IDDM data, the distribution of HLA DR al-
leles was considered to be DR3 (12%) and DR4 (13%)
(Baur et al. 1984). Alleles different from DR3 and DR4 Results
are denoted ‘‘DRX.’’ In the model with complementa-
tion effect (Clerget-Darpoux et al. 1991), the susceptibil- Under the hypothesis of parental imprinting, maternal
and paternal effects do not have the same effect. Theity to the disease comes from two speciﬁc alleles, de-
noted ‘‘a0’’ and ‘‘b0 ,’’ located at two closely linked loci probability of being affected, given an individual who
has inherited a disease allele from his or her mother,A and B in the HLA region. The recombination fractions
between A, B, and the HLA markers are assumed to be will not be equal to the probability in the presence of
paternal inheritance. Thus, the penetrances depend notnegligible. Only individuals having at least one a0 allele
or at least one b0 allele can develop the disease. We only on the genotype but also on the parental inheritance
of each allele (Margaritte-Jeannin et al. 1995). This spec-denote as ‘‘a’’ and ‘‘b’’ all other alleles different from
a0 and b0 at loci A and B, respectively. This model iﬁcation leads us to estimate the hazard-rates matrix
presented in table 1, where uppercase letters represent
hazard rates. To have a clearer view of the hazard-rates
matrices, we use the notation h11 Å H, h12 Å L, and h14Table 1 Å M. Since Margaritte-Jeannin et al. (1995) claimed the
Model 1 of Hazard-Rates Matrix, with Imprinting existence of a maternal effect, we can restrict the hazard-
rates matrix in table 2 by imposing h14 Å h41 Å M,
MATERNAL ALLELE implying the absence of paternal effect.
The difference between models 1 and 2 lies only inPATERNAL ALLELE a0b0 a0b ab0 ab
the complexity—nine parameters for the former versus
a0b0 E F G H three parameters for the latter. The MASC model with
a0b I 0 J 0 no parental imprinting is speciﬁed by requiring that haz-
ab0 K L 0 0 ard rates be symmetrical; that is, hij Å hji, which means
ab M 0 0 0
I Å F, K Å G, M Å H and J Å L in table 1 and H Å L
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Table 3
Statistics of Models with Age-Dependent Penetrances and with Penetrances Constant with Age, with and without Imprinting
MODEL 1 MODEL 2
02 Log Likelihood x2 df 02 Log Likelihood x2 df Likelihood-Ratio Test df
With age-dependent penetrances:
With imprinting 2,206.2 24.42 16 2,218.2 29.98 22 12.0 6
Without imprinting 2,205.7 30.69 20 2,222.0 35.09 23 16.3 3
Likelihood-ratio test 00.5a 4 3.8 1
With penetrances constant with age:
With imprinting 675.9 23.91 16 676.3 36.13 22 .43 6
Without imprinting 677.0 30.95 20 677.3 42.39 23 .32 3
Likelihood-ratio test 1.2 4 1.0 1
a Negative value is due to imperfect numerical convergence.
in table 2. With parental imprinting, models 1 and 2 trances and with penetrances constant with age are not
nested within one another.have, respectively, ﬁve and two parameters.
Table 3 presents the maximum-likelihood estimates Among model 2 with and without imprinting and
model 1 with imprinting, model 2 without imprintingand x2 associated with these models, with age-dependent
penetrances and with penetrances constant with age, for is the most parsimonious. Model 1 without imprinting
is signiﬁcantly different and must be preferred.our sample of 308 families. On the basis of the results
in table 3, we can test two hypotheses: (1) model 1 Table 4 presents the estimated hazard rates for model
1 with age-dependent penetrances and without im-against model 2 and (2) imprinting against absence of
imprinting, using likelihood-ratio tests. With pene- printing, with its coupling matrix presented in table 5.
Unfortunately, no inference of these coefﬁcients can betrances constant with age, models 1 and 2 are not sig-
niﬁcantly different. With age-dependent penetrances and computed with MASC yet (we will attempt this task in
a future paper).no parental imprinting, model 1 must be preferred. With
age-dependent penetrances and parental imprinting, the
likelihood-ratio test between model 1 and model 2 Discussion
equals 12.0, whereas the 5% level of x26 is 12.592: model
2 can be said to be not signiﬁcantly different from model The consideration of age at onset in genetic diseases
1. Moreover, model 2 is more parsimonious. appearing along the life cycle should better reﬂect the
Similarly, the likelihood-ratio test can be used to test process of disease expression than does consideration of
the presence of parental imprinting. Table 3 shows that penetrances constant with age. Focusing on the instanta-
there is no signiﬁcant difference, regardless of whether neous risk makes the probability of expressing the dis-
parental imprinting is considered in model 1 and in ease depend on age.
model 2, whether penetrances are constant or varying We have presented here an extension, with age, of the
with age. The signiﬁcance of age dependency cannot be MASC method ﬁrst introduced by Clerget-Darpoux et
tested formally, since models with age-dependent pene- al. (1988), which we have used to reexamine IDDM
Table 5Table 4
Model 1 with Age-Dependent Penetrances and without ParentalModel 1 without Parental Imprinting: Best-Fit Values for
Hazard-Rates Matrix Imprinting: Best-Fit Values for Matrix of Coupling Frequencies cij
MARKER ALLELEMATERNAL ALLELE
PATERNAL ALLELE a0b0 a0b ab0 ab HAPLOTYPE DR3 DR4 DRX
a0b0 .25 .34 .02a0b0 .017 .011 .014 .012
a0b .011 0 .047 0 a0b 0 .67 0
ab0 .75 0 0ab0 .014 .047 0 0
ab .012 0 0 0 ab 0 0 .98
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for IDDM by the MASC method. Genet Epidemiol 6:59–data. For the selected 308 families in which age or age
64at onset are known, the age dependent–penetrance
Clerget-Darpoux F, Babron MC, Deschamps I, Hors J (1991)model that we selected gives no signiﬁcant role to paren-
Complementation and maternal effect in insulin-dependenttal imprinting in IDDM. Although no inference of the
diabetes. Ann Hum Genet 49:42–48hazard rates has yet been made, the data in table 4 imply Clerget-Darpoux F, Babron MC, Prum B, Lathrop GM,
that the risk is highest (hij Å .047) for individuals with Deschamps I, Hors J (1988) A new method to test genetic
genotype a0b from one parent and with ab0 from the models in HLA associated diseases: the MASC method. Ann
other parent; this statement remains to be tested, how- Hum Genet 42:247–258
ever. With the same reserve with regard to inference, Clerget-Darpoux F, Dizier MH, Bonaı¨te´-Pellie´ C, Babron MC,
Hochez J, Martinez M (1986) Discrimination between ge-the risk would be quite the same for other combinations
netic models for insulin dependent diabetes mellitus. Genetinvolving at least one a0 and one b0 (.011, .012, and
Epidemiol 3 Suppl 1:313–318.017). To illustrate the consequence of these numbers,
Cox DR, Oakes D (1984) Analysis of survival data. Chap-let us mention that a 20-year-old individual at risk .047
man & Hall, London and New Yorkhas a probability of 1 0 exp(0.04720) Å .61 of having Cudworth AG, Woodrow JC (1975) Evidence for HLA linked
the disease, whereas the same probability for a 20-year- in juvenile diabetes mellitus. BMJ 3:133–135
old individual at risk .011 is only .20. These probabili- Deschamps I, Hors J, Clerget-Darpoux F, Gardais E, Robert
ties become .85 and .36, respectively, for 40-year-old J, Marcelli-Barge A, Lestradet H, et al (1990) Excess of
individuals. To determine the difference between indi- maternal HLA-DR3 antigens in HLA DR3, 4 positive type I
(insulin-dependent) diabetic patients. Diabetologia 33:425–viduals of genotype a0b b0a, with each disease allele
430coming from a different parent, and individuals of other
Elston RC (1973) Ascertainment and age of onset in pedigreegenotypes, the expectancy that an individual will live
analysis. Hum Hered 23:105–112without the disease is a good indicator: it is, respectively,
Hodge SE, Rotter JI, Lange K (1980) A three-allele model for21.3 and 90.9 years at birth and is 8.3 and 73.0 years heterogeneity of juvenile-onset insulin-dependent diabetes.
at age 20 years. In a future paper, we hope to be able Ann Hum Genet 43:349–409
to test the signiﬁcance of this important difference. Khalil I, d’Auriol L, Gobet M, Morin L, Lepage V, Deschamps
I, Sik Park M, et al (1990) A combination of HLA-DQb
Asp57 negative and HLA Arg52 confers susceptibility to
IDDM. J Clin Invest 85:1315–1319Acknowledgments
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